Companies included in SBIO
This is SBIO's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 1–92 of 92.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| KYMR | Kymera Therapeutics Inc | 70,365 | NS | 4.656891% |
| CELC | Celcuity Inc | 41,241 | NS | 3.337737% |
| ALKS | Alkermes Plc | 147,168 | NS | 3.209303% |
| CGON | Cg Oncology Inc | 71,897 | NS | 3.062802% |
| MIRM | Mirum Pharmaceuticals Inc | 45,804 | NS | 3.06259% |
| Amicus Therapeutics Inc | Amicus Therapeutics Inc | 274,988 | NS | 2.862868% |
| ACAD | Acadia Pharmaceuticals Inc | 150,789 | NS | 2.683051% |
| Newamsterdam Pharma Co Nv | Newamsterdam Pharma Co Nv | 101,063 | NS | 2.596341% |
| CRNX | Crinetics Pharmaceuticals Inc | 84,576 | NS | 2.518372% |
| APGE | Apogee Therapeutics Inc | 48,872 | NS | 2.4785% |
| VKTX | Viking Therapeutics Inc | 100,746 | NS | 2.469955% |
| GPCR | Structure Therapeutics Inc | 54,083 | NS | 2.467711% |
| XENE | Xenon Pharmaceuticals Inc | 68,873 | NS | 2.157074% |
| SYRE | Spyre Therapeutics Inc | 69,157 | NS | 2.154946% |
| EWTX | Edgewise Therapeutics Inc | 94,360 | NS | 2.080959% |
| TARS | Tarsus Pharmaceuticals Inc | 37,835 | NS | 2.070077% |
| DNLI | Denali Therapeutics Inc | 131,033 | NS | 2.010655% |
| IDYA | Ideaya Biosciences Inc | 78,135 | NS | 1.822772% |
| TVTX | Travere Therapeutics Inc | 79,744 | NS | 1.721073% |
| Apellis Pharmaceuticals Inc | Apellis Pharmaceuticals Inc | 112,768 | NS | 1.712411% |
| VERA | Vera Therapeutics Inc | 56,977 | NS | 1.683775% |
| IRON | Disc Medicine Inc | 33,646 | NS | 1.623936% |
| DNTH | Dianthus Therapeutics Inc | 38,214 | NS | 1.527966% |
| MLYS | Mineralys Therapeutics Inc | 70,537 | NS | 1.495279% |
| Galapagos Nv | Galapagos Nv | 58,387 | NS | 1.42384% |
| MAZE | Maze Therapeutics Inc | 42,889 | NS | 1.416597% |
| ZLAB | Zai Lab Ltd | 99,972 | NS | 1.392075% |
| STOK | Stoke Therapeutics Inc | 50,908 | NS | 1.342881% |
| NUVB | Nuvation Bio Inc | 305,559 | NS | 1.308318% |
| CLDX | Celldex Therapeutics Inc | 59,226 | NS | 1.291117% |
| OLMA | Olema Pharmaceuticals Inc | 70,109 | NS | 1.229193% |
| PHVS | Pharvaris Nv | 57,094 | NS | 1.174321% |
| VCEL | Vericel Corp | 45,076 | NS | 1.165202% |
| RLAY | Relay Therapeutics Inc | 154,480 | NS | 1.148287% |
| TYRA | Tyra Biosciences Inc | 47,570 | NS | 1.147991% |
| AGIO | Agios Pharmaceuticals Inc | 51,973 | NS | 1.138274% |
| SRPT | Sarepta Therapeutics Inc | 93,395 | NS | 1.13404% |
| Oculis Holding Ag | Oculis Holding Ag | 50,955 | NS | 1.085707% |
| AMLX | Amylyx Pharmaceuticals Inc | 97,879 | NS | 1.075737% |
| ORKA | Oruka Therapeutics Inc | 43,144 | NS | 1.075563% |
| NVAX | Novavax Inc | 144,833 | NS | 1.063987% |
| IMCR | Immunocore Holdings Plc | 45,035 | NS | 1.053861% |
| SION | Sionna Therapeutics Inc | 39,776 | NS | 1.052981% |
| PVLA | Palvella Therapeutics Inc | 10,552 | NS | 1.0322% |
| MBX | Mbx Biosciences Inc | 40,022 | NS | 0.943801% |
| ZBIO | Zenas Biopharma Inc | 47,842 | NS | 0.913315% |
| IMTX | Immatics Nv | 119,488 | NS | 0.895108% |
| RAPP | Rapport Therapeutics Inc | 42,477 | NS | 0.893371% |
| CRVS | Corvus Pharmaceuticals Inc | 66,564 | NS | 0.880584% |
| TSHA | Taysha Gene Therapies Inc | 244,138 | NS | 0.801243% |
| MLTX | Moonlake Immunotherapeutics | 63,143 | NS | 0.801018% |
| Day One Biopharmaceuticals Inc | Day One Biopharmaceuticals Inc | 91,514 | NS | 0.702788% |
| GERN | Geron Corp | 568,951 | NS | 0.692492% |
| MNKD | Mannkind Corp | 273,687 | NS | 0.650368% |
| CMPX | Compass Therapeutics Inc | 158,523 | NS | 0.648891% |
| AVBP | Arrivent Biopharma Inc | 36,792 | NS | 0.612273% |
| TBPH | Theravance Biopharma Inc | 45,164 | NS | 0.597154% |
| BCAX | Bicara Therapeutics Inc | 48,826 | NS | 0.593573% |
| SPRY | Ars Pharmaceuticals Inc | 88,100 | NS | 0.592318% |
| XNCR | Xencor Inc | 63,648 | NS | 0.588852% |
| Kalvista Pharmaceuticals Inc | Kalvista Pharmaceuticals Inc | 45,051 | NS | 0.531361% |
| KURA | Kura Oncology Inc | 77,558 | NS | 0.490537% |
| RIGL | Rigel Pharmaceuticals Inc | 16,180 | NS | 0.407229% |
| ANRO | Alto Neuroscience Inc | 27,688 | NS | 0.394974% |
| DSGN | Design Therapeutics Inc | 50,771 | NS | 0.384014% |
| VNDA | Vanda Pharmaceuticals Inc | 52,672 | NS | 0.340007% |
| FLGT | Fulgent Genetics Inc | 27,554 | NS | 0.306026% |
| RGNX | Regenxbio Inc | 45,118 | NS | 0.295494% |
| ALT | Altimmune Inc | 92,999 | NS | 0.290393% |
| TECX | Tectonic Therapeutic Inc | 16,682 | NS | 0.283414% |
| ZURA | Zura Bio Ltd | 57,952 | NS | 0.277944% |
| UPB | Upstream Bio Inc | 48,162 | NS | 0.267976% |
| AVXL | Anavex Life Sciences Corp | 79,635 | NS | 0.255587% |
| FBRX | Forte Biosciences Inc | 11,166 | NS | 0.244469% |
| AVIR | Atea Pharmaceuticals Inc | 69,634 | NS | 0.236101% |
| NGNE | Neurogene Inc | 13,806 | NS | 0.234953% |
| AKBA | Akebia Therapeutics Inc | 236,514 | NS | 0.22447% |
| TARA | Protara Therapeutics Inc | 46,015 | NS | 0.212025% |
| DCTH | Delcath Systems Inc | 31,472 | NS | 0.20293% |
| ACRS | Aclaris Therapeutics Inc | 96,567 | NS | 0.20079% |
| RZLT | Rezolute Inc | 82,647 | NS | 0.192204% |
| CADL | Candel Therapeutics Inc | 48,929 | NS | 0.186104% |
| BCYC | Bicycle Therapeutics Plc | 44,503 | NS | 0.184746% |
| AARD | Aardvark Therapeutics Inc | 19,407 | NS | 0.175611% |
| ARCT | Arcturus Therapeutics Holdings Inc | 25,324 | NS | 0.150995% |
| State Street Institutional Treasury Plus Money Market Fund | State Street Institutional Treasury Plus Money Market Fund | 50,717.26 | NS | 0.036744% |
| 2600057D | Novo Nordisk A/s | 1,233 | NC | 0% |
| AZN | Astrazeneca Plc | 36,586 | NC | 0% |
| 1835589D | Chinook Therapeutics Inc | 20,700 | NC | 0% |
| SECLEND | N/A | 0 | NS | 0% |
| Omniab Inc | Omniab Inc | 3,653 | NC | 0% |
| Omniab Inc | Omniab Inc | 3,653 | NC | 0% |
SEC N-PORT snapshot as of .